Future Data Group Limited — Board/Management Information 2026

Apr 8, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

FUTURE DATA GROUP LIMITED

未來數據集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8229)

APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

The board (the "Board") of directors (the "Directors") of Future Data Group Limited (the "Company", together with the subsidiaries, the "Group") announces that with effect from 8 April 2026, Dr. Liu Xiao (劉驍) ("Dr. Liu") has been appointed as an independent non-executive Director. Set out below are the biographical details of Dr. Liu:

Dr. Liu, aged 43, is a renowned professor of ophthalmology and an interdisciplinary expert in the field of medical artificial intelligence ("AI"). Dr. Liu has over ten years of experience in clinical ophthalmology and AI-assisted diagnosis research, focusing on retinal diseases and myopia control. She has been dedicated to the development and clinical application of medical imaging AI, healthcare big data, and intelligent diagnostic systems.

Dr. Liu obtained her Master of Medicine at Central South University (中南大學) in 2008 and later obtained her Doctor of Medicine in Ophthalmology from The Second Xiangya Hospital of Central South University (中南大學湘雅二醫院) in 2013.

Dr. Liu has served in the Department of Ophthalmology at The Second Xiangya Hospital of Central South University since 2013, being appointed as an Associate Chief Physician in the Department of Ophthalmology at The Second Xiangya Hospital of Central South University in 2021 and an Associate Professor in the Department of Ophthalmology at The Second Xiangya Hospital of Central South University in 2022. Her professional career is marked by significant international academic engagement, including serving as a visiting scholar at the Department of Ophthalmology of Flinders University in Australia in late 2013, and a two-year tenure as a visiting scholar at the Department of Ophthalmology and Visual Sciences at the University of Louisville in the United States from November 2016 to October 2018.

---

Pursuant to the letter of appointment entered into between Dr. Liu and the Company, Dr. Liu has been appointed as an independent non-executive Director for an initial term of two years commencing from 8 April 2026 unless terminated by not less than one month’s notice in writing served by either party on the other. Dr. Liu’s directorship in the Company is subject to retirement by rotation and re-election and other related provisions as stipulated in the articles of association of the Company and the GEM Listing Rules. Pursuant to her letter of appointment, Dr. Liu is entitled to a monthly director’s fee of HK$10,000, which was determined with reference to her background, qualifications, experience, duties and responsibilities with the Group and the prevailing market conditions.

As at the date of this announcement, Dr. Liu does not have, and is not deemed to have, any interests or short positions in any shares, underlying shares or debentures of the Company or any of its associated corporations which is required to be disclosed under Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

As at the date of this announcement and save as disclosed above, (i) Dr. Liu has not held any other major appointments and professional qualifications or directorship in other listed companies the securities of which are listed on any securities market in Hong Kong or overseas in the three years preceding the date of this announcement; (ii) Dr. Liu does not hold any other position in the Company or members of the Group; (iii) Dr. Liu does not have any relationship with any Directors, senior management, substantial or controlling shareholders (having the meaning ascribed to it under the Rules Governing the Listing of Securities on GEM of the Stock Exchange (the “GEM Listing Rules”) of the Company); and (iv) there is no other information that needs to be disclosed pursuant to the requirements of Rule 17.50(2)(h) to 17.50(2)(v) of the GEM Listing Rules nor any other matters that ought to be brought to the attention of the shareholders of the Company in relation to the appointment of Dr. Liu as an independent non-executive Director. Dr. Liu further confirmed with the Company (i) her independence as regards each of the factors referred to in Rule 5.09(1) to (8) of the GEM Listing Rules; (ii) that she has no past or present financial or other interest in the business of the Company or its subsidiaries or any connection with any core connected person (as defined in the GEM Listing Rules) of the Company; and, (iii) that there are no other factors that may affect Dr. Liu’s independence at the time of her appointment.

The Board would like to take this opportunity to extend a warm welcome to Dr. Liu in joining the Board.

By order of the Board

Future Data Group Limited

Tuen Hei Ching

Executive Director

Hong Kong, 8 April 2026

---

As at the date of this announcement, the executive Directors are Ms. Tuen Hei Ching, Mr. Lee Seung Han and Mr. Bai Yicong; the non-executive Director is Ms. Tao Hongxia; and the independent non-executive Directors are Mr. Chan Kin Ming, Mr. Lam Chi Cheung Albert, Mr. Leung Louis Ho Ming and Dr. Liu Xiao.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the "Latest Listed Company Information" page of the website of the Stock Exchange at www.hkexnews.hk for at least seven days from the day of its publication. This announcement will also be published on the Company's website at www.futuredatagroup.com.

• 3 -